{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:20:01Z","timestamp":1783542001463,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012220","name":"Hercules Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023YFE0206500"],"award-info":[{"award-number":["2023YFE0206500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012905","name":"Department of Science and Technology of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22307067"],"award-info":[{"award-number":["22307067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373727"],"award-info":[{"award-number":["82373727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["ZW13-02"],"award-info":[{"award-number":["ZW13-02"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012906","name":"Shandong Province Department of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012906","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019771","name":"KU Leuven Rega Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109758","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T15:46:12Z","timestamp":1773589572000},"page":"109758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of orally bioavailable N-acylated remdesivir derivatives with potent broad-spectrum antiviral activity"],"prefix":"10.1016","volume":"175","author":[{"given":"Letian","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leentje","family":"Persoons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109758_bb0005","series-title":"WHO Chief Declares End to COVID-19 as a Global Health Emergency","author":"World Health Organization","year":"2023"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109758_bb0010","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109758_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-med-043021-030635","article-title":"Post-COVID-19 condition","volume":"74","author":"Nalbandian","year":"2023","journal-title":"Annu. Rev. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109758_bb0020","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S1473-3099(24)00415-8","article-title":"Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109758_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109758_bb0030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijbiomac.2021.03.112","article-title":"A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase","volume":"181","author":"Khan","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"6492","key":"10.1016\/j.bioorg.2026.109758_bb0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109758_bb0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109758_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40265-022-01684-5","article-title":"Molnupiravir: first approval","volume":"82","author":"Syed","year":"2022","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109758_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02479-20","article-title":"AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109758_bb0055","article-title":"Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109758_bb0060","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109758_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-29517-9","article-title":"Expanded profiling of remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro","volume":"13","author":"Radoshitzky","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109758_bb0070","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide prodrug technology: from the concept to the clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109758_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.bioorg.2026.109758_bb0080","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s40265-020-01378-w","article-title":"Remdesivir: first approval","volume":"80","author":"Lamb","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.109758_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114800","article-title":"Remdesivir: Quo Vadis?","volume":"193","author":"De Clercq","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109758_bb0090","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40265-023-01937-x","article-title":"Correction to: remdesivir: a review in COVID-19","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.109758_bb0095","article-title":"Remdesivir in treating hospitalized patients with COVID-19: a renewed review of clinical trials","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109758_bb0100","article-title":"Remdesivir for the treatment of COVID-19","volume":"1","author":"Grundeis","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109758_bb0105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial results","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109758_bb0110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/M21-4784","article-title":"Major update 2: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians Practice Points","volume":"175","author":"Kaka","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bioorg.2026.109758_bb0115","unstructured":"https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2023.2."},{"key":"10.1016\/j.bioorg.2026.109758_bb0120","unstructured":"https:\/\/www.veklury.com\/."},{"key":"10.1016\/j.bioorg.2026.109758_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110097","article-title":"In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir","volume":"365","author":"Zhang","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109758_bb0130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/ph14070655","article-title":"ADME and pharmacokinetic properties of remdesivir: its drug interaction potential","volume":"14","author":"Deb","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109758_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/v17060836","article-title":"Pharmacokinetics and metabolism of broad-spectrum antivirals remdesivir and Obeldesivir with a consideration to metabolite GS-441524: same, similar, or different?","volume":"17","author":"Babusis","year":"2025","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109758_bb0140","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1021\/acs.jmedchem.4c00234","article-title":"Differential bioactivation profiles of different GS-441524 prodrugs in cell and mouse models: ProTide prodrugs with high cell permeability and susceptibility to cathepsin A are more efficient in delivering antiviral active metabolites to the lung","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109758_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01155-21","article-title":"Rethinking remdesivir: synthesis, antiviral activity, and pharmacokinetics of oral lipid prodrugs","volume":"65","author":"Schooley","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109758_bb0150","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1021\/acs.jmedchem.3c00046","article-title":"1-O-Octadecyl-2-O-benzyl-sn-glyceryl-3-phospho-GS-441524 (V2043). Evaluation of Oral V2043 in a mouse model of SARS-CoV-2 infection and synthesis and antiviral evaluation of additional phospholipid esters with enhanced anti-SARS-CoV-2 activity","volume":"66","author":"Carlin","year":"2023","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109758_bb0155","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.apsb.2025.02.028","article-title":"Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"661","key":"10.1016\/j.bioorg.2026.109758_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm7621","article-title":"The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants","volume":"14","author":"Cao","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109758_bb0165","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41422-021-00570-1","article-title":"Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2","volume":"31","author":"Xie","year":"2021","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109758_bb0170","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2208822","article-title":"VV116 versus nirmatrelvir-ritonavir for oral treatment of Covid-19","volume":"388","author":"Cao","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109758_bb0175","volume":"7","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bioorg.2026.109758_bb0180","series-title":"Innovative Drug Approved for the Treatment of COVID-19 in Uzbekistan","author":"Chinese Academy of Sciences","year":"2023"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109758_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020670","article-title":"Optimization of SARS-CoV-2 Mpro inhibitors by a structure-based multilevel virtual screening method","volume":"26","author":"Jing","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109758_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"issue":"7594","key":"10.1016\/j.bioorg.2026.109758_bb0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109758_bb0200","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1021\/acsmedchemlett.0c00316","article-title":"Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment","volume":"11","author":"Yan","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109758_bb0205","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/cts.12815","article-title":"What do we know about remdesivir drug interactions?","volume":"13","author":"Yang","year":"2020","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109758_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jviromet.2005.05.010","article-title":"Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus","volume":"129","author":"Ivens","year":"2005","journal-title":"J. Virol. Methods"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109758_bb0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jviromet.2012.04.011","article-title":"A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE","volume":"183","author":"Jochmans","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bioorg.2026.109758_bb0220","series-title":"GS-441524 Studies","author":"National Center for Advancing Translational Sciences (NCATS) of National Institutes of Health (NIH)","year":"2024"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109758_bb0225","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.apsb.2021.03.028","article-title":"Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment","volume":"11","author":"Xie","year":"2021","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:32:49Z","timestamp":1783539169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["S0045206826002944"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109758","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of orally bioavailable N-acylated remdesivir derivatives with potent broad-spectrum antiviral activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109758"}}